None of the developments in medicine is beneficial, if it does not reach the patient. For this reason, the Professional Association of the German Urologists (Berufsverband der Deutschen Urologen e.V., BDU) wants to translate the new S3 Guidelines for the treatment of the prostate carcinoma into practice. In a statewide initiative furthering education, the currently available knowledge of early detection, diagnosis, and therapies is to be conveyed to all urologists in German. According to the President of the Association, Dr. Martin Bloch, the stated objective of the BDU is that patients profit as quickly as possible from the new developments, and receive “beneficial treatment in accordance with the guidelines”.
More than 70 per cent of all diagnosed prostate carcinoma are currently in an organ-defined and thus potentially treatable stage. “Thanks to the improved early detection methods”, so Dr. Pedram Derakhshani, urologist at the West-German Prostate Center, “we detect also those kind of carcinoma that would generally not have been discovered, and which would possibly not have caused any problems during the lifetime of the patient” „Against this background, treatment options such as low-risk brachytherapy or defensive strategies, e.g. the active surveillance, gain great importance”, explains Dr. Derakhshani. The currently implemented S3 Guidelines take these developments into account, since they focus especially on the life quality of the patients and thereby emphasize low-risk treatment methods with fewer side effects.